Oxford-based medical device company OrganOx raised €29 million to transform organ transplantation practices

Published on July 17, 2023

OrganOx, a commercial-stage medical device company, raised €29 million growth investment led by Lauxera Capital Partners to further develop and commercialize organ preservation and transportation devices designed to directly save lives by increasing the supply of organs available for transplantation. OrganOx’s mission is to increase the number of organs available for transplantation. Its metra device…

This content is for members only. Visit the site and log in/register to read.

The post Oxford-based medical device company OrganOx raised €29 million to transform organ transplantation practices appeared first on EU-Startups.